Pulmonary bacterial coinfection in infants and children with viral respiratory infection

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 8, 2012, Pages 909-916

  Thorburn, Kentigern ^a,b   Riordan, Andrew ^a,b  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

bacterial coinfection; children; concomitant pneumonia; infants; influenza; respiratory syncytialvirus

Indexed keywords

BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION SENSITIVITY; INFLUENZA; LUNG INFECTION; MIXED INFECTION; MORAXELLA CATARRHALIS; NONHUMAN; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; VIRAL BRONCHIOLITIS; VIRAL RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; COINFECTION; COMORBIDITY; HUMANS; INCIDENCE; INFANT; INFLUENZA, HUMAN; LUNG DISEASES; ORTHOMYXOVIRIDAE; PNEUMONIA, BACTERIAL; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS;

EID: 84867034203     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.80     Document Type: Review

References (35)

1. Randolph AG, Vaughn F, Sullivan R et al.; Pediatric Acute Lung Injury and Sepsis Investigator's Network and the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 128(6), e1450-e1458 (2011).
2. Finelli L, Fiore A, Dhara R et al. Influenzaassociated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122(4), 805-811 (2008).
3. Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin. Microbiol. Infect. 14(4), 298-306 (2008).
4. Hall CB, Weinberg GA, Iwane MK et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360(6), 588-598 (2009).
5. Nair H, Nokes DJ, Gessner BD et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375(9725), 1545-1555 (2010).
6. Spurling GK, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database Syst. Rev. 6, CD005189 (2011).
7. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr. Infect. Dis. J. 23(11), 990-994 (2004).
8. Kneyber MCJ, Kimpen JLL. Antibiotics in RSV bronchiolitis: still no evidence of effect. Eur. Respir. J. 29, 1285 (2007).
9. Lynch T, Bialy L, Kellner JD et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS ONE 5(8), e11989 (2010).
10. Harris M, Clark J, Coote N, et al.; British Thoracic Society of Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood: update. Thorax 56, ii1-ii23 (2011).
11. Michelow IC, Olsen K, Lozano J et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113(4), 701-707 (2004).
12. Hishiki H, Ishiwada N, Fukasawa C et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J. Infect. Chemother. 17(1), 87-90 (2011).
13. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61(7), 611-615 (2006).
14. Thorburn K, Shetty N, Darbyshire AP. Concomitant bacterial pneumonia and empirical antibiotics in severe respiratory syncytial virus infection. Pediatr. Crit. Care Med. 12(1), 119; author reply 119-120 (2011).
15. Resch B, Gusenleitner W, Mueller WD. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr. 96(4), 495-498 (2007).
16. Levin D, Tribuzio M, Green-Wrzesinki T et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: a prospective study and evidence review. Pediatr. Crit. Care Med. 11(3), 390-395 (2010).
17. Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch. Dis. Child. 89(4), 363-367 (2004).
18. Hall CB. Serious bacterial infections is uncommon in infants with bronchiolitis. J. Pediatr. 154(5), 774-775 (2009).
19. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr. Infect. Dis. J. 27(10), 939-941 (2008).
20. Streng A, Grote V, Liese JG. Severe influenza cases in paediatric intensive care units in Germany during the pre-pandemic seasons 2005-2008. BMC Infect. Dis. 11, 233 (2011).
21. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23(1), 74-98 (2010).
22. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26(3-4), 189-195 (1999).
23. McCullers JC. Insights into the interactions between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571-582 (2006).
24. Avadhanula V, Rodriguez CA, Devincenzo JP et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral speciesand cell type-dependent manner. J. Virol. 80(4), 1629-1636 (2006).
25. World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Illnesses With Limited Resources. WHO press, Geneva, Switzerland, 72-81 (2005).
26. Principi N, Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax 66(9), 815-822 (2011).
27. Korppi M. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. Paediatr. Drugs 5(12), 821-832 (2003).
28. American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 118, 1774-1793 (2006).
29. Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr. Infect. Dis. J. 27(2), 95-99 (2008).
30. Berg P, Lindhardt BO. The role of procalcitonin in adult patients with community-acquired pneumonia-a systematic review. Dan. Med. J. 59(3), A4357 (2012).
31. Esposito S, Tagliabue C, Picciolli I et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir. Med. 105(12), 1939-1945 (2011).
32. Piedra PA, Schulman KL, Blumentals WA. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 124(1), 170-178 (2009).
33. Reed C, Kallen AJ, Patton M et al. Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr. Infect. Dis. J. 28(7), 572-576 (2009).
34. van Woensel JB, von Rosenstiel IA, Kimpen JL, Spanjaard L, van Aalderen WM. Antibiotic use in pediatric intensive care patients with lower respiratory tract infection due to respiratory syncytial virus. Intensive Care Med. 27(8), 1436 (2001).
35. Kneyber MC, Blussé van Oud-Alblas H, van Vliet M, Uiterwaal CS, Kimpen JL, van Vught AJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med. 31(5), 680-685 (2005).